Holen Sie sich die Stockscreener-App
2.64
4.35%
-0.12
Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
25.46%
28.02
|
22.33 | 23.12 | 21.65 | 30.69 |
| Depreciation and Amortization |
1.37%
0.074
|
0.073 | 0.073 | 0.073 | 0.062 |
| Operating Income/Loss |
25.46%
-28.02
|
-22.33 | -23.12 | -21.65 | -30.69 |
| Nonoperating Income/Loss |
0.75%
2.153
|
2.137 | 2.197 | 1.365 | 4.585 |
| Income/Loss From Continuing Operations Before Tax |
28.08%
-25.87
|
-20.20 | -20.63 | -20.28 | -26.10 |
| Net Income/Loss |
28.08%
-25.87
|
-20.20 | -20.92 | -20.28 | -26.10 |
| Basic Average Shares |
5.47%
85.63
|
81.18 | - | 60.98 | 43.57 |
| Diluted Average Shares |
5.47%
85.63
|
81.18 | - | 60.98 | 43.57 |
| Basic Earnings Per Share |
20.00%
-0.30
|
-0.25 | - | -0.33 | -0.60 |
| Diluted Earnings Per Share |
20.00%
-0.30
|
-0.25 | - | -0.33 | -0.60 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):